Interferon Not Included: Say Goodbye to Hepatitis C

Share

Follow Us

Print this page

Newest Hepatitis C Drug Without Interferon Achieves 93 Percent Cure Rate

Written by David Heitz

Another pharmaceutical company appears headed to market with a drug that cures hepatitis C genotype 1, without interferon and ribavirin, in just 12 weeks.

Research published today in The Journal of the American Medical Association (JAMA) showed a combination of Bristol-Myers Squibb drugs daclatasvir, asunaprevir, and beclabuvir cured hepatitis C in 93 percent of 112 study participants with cirrhosis who had not previously been treated.

Continue reading this entire article:
http://www.healthline.com/health-news/newest-hepatitis-c-drug-without-interferon-achieves-93-percent-cure-rate-050515

Download Our Free Reports

Inside you'll discover:

• Things You May Not Know About Hepatitis C
• 7 Liver Detox SUPER Foods Your Doctor Isn't Telling You About
• 5 Dangerous Foods That Will Wreak Havoc On Your Liver
• A free "Mystery" Gift Valued at $9.99

Email address

Download Now

You'll also receive the latest news and information to support liver health.
Rest assured, we will not rent your email to anyone.